The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus
The group I specific metabotropic glutamate (mGlu) receptor agonist ( RS)-3,5-dihydroxyphenylglycine (DHPG) (100 μM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In “normal” (1...
Gespeichert in:
Veröffentlicht in: | Neuropharmacology 1997-11, Vol.36 (11), p.1517-1532 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1532 |
---|---|
container_issue | 11 |
container_start_page | 1517 |
container_title | Neuropharmacology |
container_volume | 36 |
creator | Palmer, M.J. Irving, A.J. Seabrook, G.R. Jane, D.E. Collingridge, G.L. |
description | The group I specific metabotropic glutamate (mGlu) receptor agonist (
RS)-3,5-dihydroxyphenylglycine (DHPG) (100 μM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In “normal” (1 mM Mg
2+-containing) medium, LTD (measured 30 min after washout of DHPG) was small (13 ± 3%), but LTD was enhanced if DHPG was applied when the tissue was made hyperexcitable, either by omitting Mg
2+ from the perfusate (35 ± 3%) or by adding the GABA
A receptor antagonist picrotoxin (29 ± 2%). The
N-methyl-
D-aspartate (NMDA) receptor antagonist AP5 (100 μM) substantially reduced the generation of DHPG-induced LTD in Mg
2+-free medium, but had little effect on LTD induced in the presence of picrotoxin. In Mg
2+-free medium, the threshold concentration of DHPG required to induce LTD was between 1 and 3 μM. Neither agonists specific for group II (100 nM DCG-IV or 1 μM LY354740) or group III (10 μM
l-AP4) mGlu receptors or a combined group I and II agonist (30–100 μM (1
S,3
R)-ACPD) induced LTD. However, an agonist (1 mM CHPG) which activates mGlu
5 but not mGlu
1 receptors did induce LTD. Surprisingly, DHPG-induced LTD was reversed by mGlu receptor antagonists, applied hours after washout of DHPG. DHPG-induced LTD did not occlude with LTD induced by synaptic activation (1200 stimuli delivered at 2 Hz), in Mg
2+-free medium. These data show that activation of group I mGlu receptors (probably mGlu
5) can induce LTD and that this mGlu receptor-mediated LTD may, or may not, require activation of NMDA receptors, depending on the experimental conditions. |
doi_str_mv | 10.1016/S0028-3908(97)00181-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79574649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390897001810</els_id><sourcerecordid>79574649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-f76a819820a0f1e5539663253652aa2c9b0444d7899064c76bc4a6b34df3256b3</originalsourceid><addsrcrecordid>eNqFkc1qGzEUhUVpSZ20jxDQopRmMc2VRr-rEpzECRgaqLsWskbjqMyMptJMoG9fOTbeZiWh850r6RyELgl8J0DE9S8Aqqpag_qm5RUAUaSCd2hBlKwrCYK9R4sT8hGd5_wHAJgi6gydaU4ko3SBdptnj3cpziN-xP2qm3Hyzo9TTNju4hDyhG8fnlY4DM3sfMYWD_HFd7iNqcexxevNbdHwVKYsb0gx70Ic9sL-5DmMY3S2H-f8CX1obZf95-N6gX7f322WD9X65-pxebOuHK_VVLVSWEW0omChJZ7zWgtRU14LTq2lTm-BMdZIpXX5oZNi65gV25o1baHK5gJ9PcwdU_w7-zyZPmTnu84OPs7ZSM0lE0y_CRLBGaEgC8gPoEsx5-RbM6bQ2_TPEDD7JsxrE2Yfs9HSvDZhoPgujxfM2943J9cx-qJ_Oeo2O9u1yQ4u5BNGCdNCqoL9OGC-pPYSfDLZBT8434TS1GSaGN54yH8dcKHW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16541207</pqid></control><display><type>article</type><title>The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Palmer, M.J. ; Irving, A.J. ; Seabrook, G.R. ; Jane, D.E. ; Collingridge, G.L.</creator><creatorcontrib>Palmer, M.J. ; Irving, A.J. ; Seabrook, G.R. ; Jane, D.E. ; Collingridge, G.L.</creatorcontrib><description>The group I specific metabotropic glutamate (mGlu) receptor agonist (
RS)-3,5-dihydroxyphenylglycine (DHPG) (100 μM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In “normal” (1 mM Mg
2+-containing) medium, LTD (measured 30 min after washout of DHPG) was small (13 ± 3%), but LTD was enhanced if DHPG was applied when the tissue was made hyperexcitable, either by omitting Mg
2+ from the perfusate (35 ± 3%) or by adding the GABA
A receptor antagonist picrotoxin (29 ± 2%). The
N-methyl-
D-aspartate (NMDA) receptor antagonist AP5 (100 μM) substantially reduced the generation of DHPG-induced LTD in Mg
2+-free medium, but had little effect on LTD induced in the presence of picrotoxin. In Mg
2+-free medium, the threshold concentration of DHPG required to induce LTD was between 1 and 3 μM. Neither agonists specific for group II (100 nM DCG-IV or 1 μM LY354740) or group III (10 μM
l-AP4) mGlu receptors or a combined group I and II agonist (30–100 μM (1
S,3
R)-ACPD) induced LTD. However, an agonist (1 mM CHPG) which activates mGlu
5 but not mGlu
1 receptors did induce LTD. Surprisingly, DHPG-induced LTD was reversed by mGlu receptor antagonists, applied hours after washout of DHPG. DHPG-induced LTD did not occlude with LTD induced by synaptic activation (1200 stimuli delivered at 2 Hz), in Mg
2+-free medium. These data show that activation of group I mGlu receptors (probably mGlu
5) can induce LTD and that this mGlu receptor-mediated LTD may, or may not, require activation of NMDA receptors, depending on the experimental conditions.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/S0028-3908(97)00181-0</identifier><identifier>PMID: 9517422</identifier><identifier>CODEN: NEPHBW</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>( RS)-2-chloro-5-hydroxyphenylglycine ; ( RS)-3,5-dihydroxyphenylglycine ; ( S)-2-amino-4-phosphonobutanoic acid ; (2S,1′R,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl)glycine ; Animals ; Biological and medical sciences ; Central nervous system ; Central neurotransmission. Neuromudulation. Pathways and receptors ; CHPG ; DCG-IV ; Depression, Chemical ; DHPG ; Electric Stimulation ; Electrophysiology ; Excitatory Amino Acid Agonists - pharmacology ; Female ; Fundamental and applied biological sciences. Psychology ; GABA-A Receptor Agonists ; Glutamate ; Glycine - analogs & derivatives ; Glycine - pharmacology ; hippocampal ; Hippocampus - drug effects ; In Vitro Techniques ; l-AP4 ; long-term depression ; LTD ; metabotropic glutamate (mGlu) receptor ; N-methyl- D-aspartate (NMDA) receptor ; Neuronal Plasticity - drug effects ; Rats ; Resorcinols - pharmacology ; synaptic plasticity ; Synaptic Transmission - drug effects ; Vertebrates: nervous system and sense organs</subject><ispartof>Neuropharmacology, 1997-11, Vol.36 (11), p.1517-1532</ispartof><rights>1998</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-f76a819820a0f1e5539663253652aa2c9b0444d7899064c76bc4a6b34df3256b3</citedby><cites>FETCH-LOGICAL-c538t-f76a819820a0f1e5539663253652aa2c9b0444d7899064c76bc4a6b34df3256b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0028390897001810$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2149678$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9517422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Palmer, M.J.</creatorcontrib><creatorcontrib>Irving, A.J.</creatorcontrib><creatorcontrib>Seabrook, G.R.</creatorcontrib><creatorcontrib>Jane, D.E.</creatorcontrib><creatorcontrib>Collingridge, G.L.</creatorcontrib><title>The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The group I specific metabotropic glutamate (mGlu) receptor agonist (
RS)-3,5-dihydroxyphenylglycine (DHPG) (100 μM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In “normal” (1 mM Mg
2+-containing) medium, LTD (measured 30 min after washout of DHPG) was small (13 ± 3%), but LTD was enhanced if DHPG was applied when the tissue was made hyperexcitable, either by omitting Mg
2+ from the perfusate (35 ± 3%) or by adding the GABA
A receptor antagonist picrotoxin (29 ± 2%). The
N-methyl-
D-aspartate (NMDA) receptor antagonist AP5 (100 μM) substantially reduced the generation of DHPG-induced LTD in Mg
2+-free medium, but had little effect on LTD induced in the presence of picrotoxin. In Mg
2+-free medium, the threshold concentration of DHPG required to induce LTD was between 1 and 3 μM. Neither agonists specific for group II (100 nM DCG-IV or 1 μM LY354740) or group III (10 μM
l-AP4) mGlu receptors or a combined group I and II agonist (30–100 μM (1
S,3
R)-ACPD) induced LTD. However, an agonist (1 mM CHPG) which activates mGlu
5 but not mGlu
1 receptors did induce LTD. Surprisingly, DHPG-induced LTD was reversed by mGlu receptor antagonists, applied hours after washout of DHPG. DHPG-induced LTD did not occlude with LTD induced by synaptic activation (1200 stimuli delivered at 2 Hz), in Mg
2+-free medium. These data show that activation of group I mGlu receptors (probably mGlu
5) can induce LTD and that this mGlu receptor-mediated LTD may, or may not, require activation of NMDA receptors, depending on the experimental conditions.</description><subject>( RS)-2-chloro-5-hydroxyphenylglycine</subject><subject>( RS)-3,5-dihydroxyphenylglycine</subject><subject>( S)-2-amino-4-phosphonobutanoic acid</subject><subject>(2S,1′R,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl)glycine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Central nervous system</subject><subject>Central neurotransmission. Neuromudulation. Pathways and receptors</subject><subject>CHPG</subject><subject>DCG-IV</subject><subject>Depression, Chemical</subject><subject>DHPG</subject><subject>Electric Stimulation</subject><subject>Electrophysiology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GABA-A Receptor Agonists</subject><subject>Glutamate</subject><subject>Glycine - analogs & derivatives</subject><subject>Glycine - pharmacology</subject><subject>hippocampal</subject><subject>Hippocampus - drug effects</subject><subject>In Vitro Techniques</subject><subject>l-AP4</subject><subject>long-term depression</subject><subject>LTD</subject><subject>metabotropic glutamate (mGlu) receptor</subject><subject>N-methyl- D-aspartate (NMDA) receptor</subject><subject>Neuronal Plasticity - drug effects</subject><subject>Rats</subject><subject>Resorcinols - pharmacology</subject><subject>synaptic plasticity</subject><subject>Synaptic Transmission - drug effects</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1qGzEUhUVpSZ20jxDQopRmMc2VRr-rEpzECRgaqLsWskbjqMyMptJMoG9fOTbeZiWh850r6RyELgl8J0DE9S8Aqqpag_qm5RUAUaSCd2hBlKwrCYK9R4sT8hGd5_wHAJgi6gydaU4ko3SBdptnj3cpziN-xP2qm3Hyzo9TTNju4hDyhG8fnlY4DM3sfMYWD_HFd7iNqcexxevNbdHwVKYsb0gx70Ic9sL-5DmMY3S2H-f8CX1obZf95-N6gX7f322WD9X65-pxebOuHK_VVLVSWEW0omChJZ7zWgtRU14LTq2lTm-BMdZIpXX5oZNi65gV25o1baHK5gJ9PcwdU_w7-zyZPmTnu84OPs7ZSM0lE0y_CRLBGaEgC8gPoEsx5-RbM6bQ2_TPEDD7JsxrE2Yfs9HSvDZhoPgujxfM2943J9cx-qJ_Oeo2O9u1yQ4u5BNGCdNCqoL9OGC-pPYSfDLZBT8434TS1GSaGN54yH8dcKHW</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Palmer, M.J.</creator><creator>Irving, A.J.</creator><creator>Seabrook, G.R.</creator><creator>Jane, D.E.</creator><creator>Collingridge, G.L.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19971101</creationdate><title>The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus</title><author>Palmer, M.J. ; Irving, A.J. ; Seabrook, G.R. ; Jane, D.E. ; Collingridge, G.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-f76a819820a0f1e5539663253652aa2c9b0444d7899064c76bc4a6b34df3256b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>( RS)-2-chloro-5-hydroxyphenylglycine</topic><topic>( RS)-3,5-dihydroxyphenylglycine</topic><topic>( S)-2-amino-4-phosphonobutanoic acid</topic><topic>(2S,1′R,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl)glycine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Central nervous system</topic><topic>Central neurotransmission. Neuromudulation. Pathways and receptors</topic><topic>CHPG</topic><topic>DCG-IV</topic><topic>Depression, Chemical</topic><topic>DHPG</topic><topic>Electric Stimulation</topic><topic>Electrophysiology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GABA-A Receptor Agonists</topic><topic>Glutamate</topic><topic>Glycine - analogs & derivatives</topic><topic>Glycine - pharmacology</topic><topic>hippocampal</topic><topic>Hippocampus - drug effects</topic><topic>In Vitro Techniques</topic><topic>l-AP4</topic><topic>long-term depression</topic><topic>LTD</topic><topic>metabotropic glutamate (mGlu) receptor</topic><topic>N-methyl- D-aspartate (NMDA) receptor</topic><topic>Neuronal Plasticity - drug effects</topic><topic>Rats</topic><topic>Resorcinols - pharmacology</topic><topic>synaptic plasticity</topic><topic>Synaptic Transmission - drug effects</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palmer, M.J.</creatorcontrib><creatorcontrib>Irving, A.J.</creatorcontrib><creatorcontrib>Seabrook, G.R.</creatorcontrib><creatorcontrib>Jane, D.E.</creatorcontrib><creatorcontrib>Collingridge, G.L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palmer, M.J.</au><au>Irving, A.J.</au><au>Seabrook, G.R.</au><au>Jane, D.E.</au><au>Collingridge, G.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>36</volume><issue>11</issue><spage>1517</spage><epage>1532</epage><pages>1517-1532</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><coden>NEPHBW</coden><abstract>The group I specific metabotropic glutamate (mGlu) receptor agonist (
RS)-3,5-dihydroxyphenylglycine (DHPG) (100 μM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In “normal” (1 mM Mg
2+-containing) medium, LTD (measured 30 min after washout of DHPG) was small (13 ± 3%), but LTD was enhanced if DHPG was applied when the tissue was made hyperexcitable, either by omitting Mg
2+ from the perfusate (35 ± 3%) or by adding the GABA
A receptor antagonist picrotoxin (29 ± 2%). The
N-methyl-
D-aspartate (NMDA) receptor antagonist AP5 (100 μM) substantially reduced the generation of DHPG-induced LTD in Mg
2+-free medium, but had little effect on LTD induced in the presence of picrotoxin. In Mg
2+-free medium, the threshold concentration of DHPG required to induce LTD was between 1 and 3 μM. Neither agonists specific for group II (100 nM DCG-IV or 1 μM LY354740) or group III (10 μM
l-AP4) mGlu receptors or a combined group I and II agonist (30–100 μM (1
S,3
R)-ACPD) induced LTD. However, an agonist (1 mM CHPG) which activates mGlu
5 but not mGlu
1 receptors did induce LTD. Surprisingly, DHPG-induced LTD was reversed by mGlu receptor antagonists, applied hours after washout of DHPG. DHPG-induced LTD did not occlude with LTD induced by synaptic activation (1200 stimuli delivered at 2 Hz), in Mg
2+-free medium. These data show that activation of group I mGlu receptors (probably mGlu
5) can induce LTD and that this mGlu receptor-mediated LTD may, or may not, require activation of NMDA receptors, depending on the experimental conditions.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>9517422</pmid><doi>10.1016/S0028-3908(97)00181-0</doi><tpages>16</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3908 |
ispartof | Neuropharmacology, 1997-11, Vol.36 (11), p.1517-1532 |
issn | 0028-3908 1873-7064 |
language | eng |
recordid | cdi_proquest_miscellaneous_79574649 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | ( RS)-2-chloro-5-hydroxyphenylglycine ( RS)-3,5-dihydroxyphenylglycine ( S)-2-amino-4-phosphonobutanoic acid (2S,1′R,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl)glycine Animals Biological and medical sciences Central nervous system Central neurotransmission. Neuromudulation. Pathways and receptors CHPG DCG-IV Depression, Chemical DHPG Electric Stimulation Electrophysiology Excitatory Amino Acid Agonists - pharmacology Female Fundamental and applied biological sciences. Psychology GABA-A Receptor Agonists Glutamate Glycine - analogs & derivatives Glycine - pharmacology hippocampal Hippocampus - drug effects In Vitro Techniques l-AP4 long-term depression LTD metabotropic glutamate (mGlu) receptor N-methyl- D-aspartate (NMDA) receptor Neuronal Plasticity - drug effects Rats Resorcinols - pharmacology synaptic plasticity Synaptic Transmission - drug effects Vertebrates: nervous system and sense organs |
title | The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T17%3A11%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20group%20I%20mGlu%20receptor%20agonist%20DHPG%20induces%20a%20novel%20form%20of%20LTD%20in%20the%20CA1%20region%20of%20the%20hippocampus&rft.jtitle=Neuropharmacology&rft.au=Palmer,%20M.J.&rft.date=1997-11-01&rft.volume=36&rft.issue=11&rft.spage=1517&rft.epage=1532&rft.pages=1517-1532&rft.issn=0028-3908&rft.eissn=1873-7064&rft.coden=NEPHBW&rft_id=info:doi/10.1016/S0028-3908(97)00181-0&rft_dat=%3Cproquest_cross%3E79574649%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16541207&rft_id=info:pmid/9517422&rft_els_id=S0028390897001810&rfr_iscdi=true |